Artiz, Judy Ann D.
HRN: 22-17-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2024
07/26/2024
IV
500 Mg
Q8
SP 1LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes